What is Integra LifeSciences's specialty surgery — goodwill?

Integra LifeSciences (IART) reported specialty surgery — goodwill of $341.92M in Q2 2026.

What does specialty surgery — goodwill mean?

This represents the carrying value of goodwill allocated to the Specialty Surgery segment, typically arising from past business acquisitions. It reflects the premium paid over the fair value of net identifiable assets, serving as a long-term indicator of historical M&A activity and potential impairment risk.

Integra LifeSciences (IART) Specialty Surgery — Goodwill

Screener

Other segment segments

Tissue Reconstruction

$269.22M—

Similar metrics at other companies

PFG

PFGCSpecialty — Goodwill

$133.4M0.0%

SUNBSpecialty — Goodwill

$1.11B+6.6%

BGSSpecialty — Goodwill

$219.25M-2.0%

CNASpecialty — Goodwill

$117M0.0%

AMRXSpecialty — Goodwill

$366.31M0.0%

RDNSpecialty — Goodwill

$5M—

Other financials

Income statement

See full

Revenue$418.8M+0.8%

Gross profit$219.7M+5.0%

Operating income$19.3M+104%

Net income$4.5M+101%

EPS (diluted)$0.06+101%

Balance sheet

See full

Cash & equivalents$214.4M-1.6%

Total debt$2.0B+3.2%

Total equity$1.0B+0.5%

Total assets$3.6B-2.8%

Cash flow

See full

Operating cash flow$22.8M+156%

CapEx$12.3M-38.9%

Free cash flow$10.5M+193%

Valuation

See full

Market cap$1.33B+38.0%

Enterprise value$3.08B+16.2%

P/S0.8×+0.2×

Profitability

See full

Gross margin52.5%-0.1pp

Operating margin2.6%+1.3pp

Net margin-0.4%—

FCF margin3.8%-6.3pp

Returns & leverage

See full

Return on equity-0.7%—

Debt / equity1.9×+0.1×

Current ratio3.6×+2.4×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.

Filed: Jul 29, 2026, 4:03 PM EDT
Fiscal quarter: Q2 FY2026
Calendar quarter: Q2 2026
Accession: 0000917520-26-000058

Dollars in thousands	Specialty Surgery	Tissue Reconstruction	Total
Goodwill at December 31, 2025	$344,167	$270,990	$615,157
Foreign currency translation	(2,245)	(1,767)	(4,012)
Goodwill at June 30, 2026	$341,922	$269,223	$611,145

Item 1. Financial Statements

FAQ

What is Integra LifeSciences's specialty surgery — goodwill?: Integra LifeSciences (IART) reported specialty surgery — goodwill of $341.92M in Q2 2026.
What does specialty surgery — goodwill mean?: This represents the carrying value of goodwill allocated to the Specialty Surgery segment, typically arising from past business acquisitions. It reflects the premium paid over the fair value of net identifiable assets, serving as a long-term indicator of historical M&A activity and potential impairment risk.